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DObjectives: In the Single Ventricle Reconstruction trial, infants undergoing the Norwood procedure were ran-
domly allocated to undergo a right ventricle-to-pulmonary artery shunt or a modified Blalock-Taussig shunt.
Apart from shunt type, subjects received the local standard of care. We evaluated variation in perioperative
care during the Norwood hospitalization across 14 trial sites.
Methods:Data on preoperative, operative, and postoperative variables for 546 enrolled subjectswho underwent the
Norwood procedurewere collected prospectively on standardized case report forms, and variation across the centers
was described.
Results: Gestational age, birth weight, and proportion with hypoplastic left heart syndrome were similar across
sites. In contrast, all recorded variables related to preoperative care varied across centers, including fetal diagnosis
(range, 55%-85%), preoperative intubation (range, 29%-91%), and enteral feeding. Perioperative and operative
factors were also variable across sites, includingmedian total support time (range, 74-189minutes) and other per-
fusion variables, arch reconstruction technique, intraoperative medication use, and use of modified ultrafiltration
(range, 48%-100%). Additional variation across centers was seen in variables related to postoperative care, in-
cluding proportionwith an open sternum (range, 35%-100%), median intensive care unit stay (range, 9-44 days),
type of feeding at discharge, and enrollment in a home monitoring program (range, 1%-100%; 5 sites did not
have a program). Overall, in-hospital death or transplant occurred in 18% (range across sites, 7%-39%).
Conclusions: Perioperative care during the Norwood hospitalization varies across centers. Further analysis eval-
uating the underlying causes and relationship of this variation to outcome is needed to inform future studies and
quality improvement efforts. (J Thorac Cardiovasc Surg 2012;144:915-21)The Norwood procedure for infants with hypoplastic left
heart syndrome was first described in 1981.1 During the
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Abbreviations and Acronyms
DHCA ¼ deep hypothermic cardiac arrest
ICU ¼ intensive care unit
IQR ¼ interquartile range
RCP ¼ regional cerebral perfusion
SVR ¼ Single Ventricle Reconstruction [trial]
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Dinfants undergoing the Norwood procedure for hypoplastic
left heart syndrome or related single right ventricle anoma-
lies were randomly allocated to receive the right ventricle-
to-pulmonary artery shunt or modified Blalock-Taussig
shunt as the source of pulmonary blood flow.5 The primary
end point, transplant-free survival 12 months after
randomization, was significantly higher in the right ventri-
cle-to-pulmonary artery shunt group than in the modified
Blalock-Taussig shunt group (74% vs 64%; P ¼ .01).5
Follow-up of the trial cohort continues, to evaluate whether
this survival benefit is maintained.5
Apart from shunt type, subjects enrolled in the SVR trial
received local standard of care, and detailed preoperative, op-
erative, and postoperative informationwas prospectively col-
lected.Evaluation of these data provides a uniqueopportunity
to describe the range of care across centers and to assess var-
iation in a large, well-characterized cohort. This is an impor-
tant first step in identification of areas of potential future
research focus and quality improvement. Previous studies
have suggested variation in several aspects of care for patients
undergoing the Norwood procedure, but they have been
limited in scope and by the use of retrospective survey meth-
odology.4,6,7 The purposes of this analysis were to describe
the range of perioperative care during the Norwood
hospitalization across sites participating in the SVR trial
and to quantitate the degree of interinstitutional variation.
MATERIALS AND METHODS
Patient Population and Trial Design
Details of the SVR trial design (ClinicalTrials.gov number
NCT00115934) have been published previously.8 In brief, infants with
a diagnosis of single, morphological right ventricle undergoing the Nor-
wood procedure were eligible for inclusion in the trial. Exclusion criteria
included single morphological left ventricle, preoperative anatomic fea-
tures rendering either a modified Blalock-Taussig shunt or a right ventri-
cle-to-pulmonary artery shunt technically impossible, and any major
congenital or acquired extracardiac abnormality thought to independently
affect survival or need for cardiac transplantation. Patients were random-
ized during 2005 through 2008 at 15 North American clinical centers
with 39 surgeons participating. Dynamic allocation within surgeon was
used to ensure that no single surgeon had a preponderance of either shunt
type. All of the sites were medium- or high-volume congenital heart sur-
gery sites. For the purposes of this analysis, a site that enrolled only 3 pa-
tients during the trial was excluded. In the remaining 14 sites, the number of
patients enrolled per site ranged from 10 to 101 (median, 34). The SVR
trial was approved by the institutional review boards at all participating in-
stitutions, and informed consent was obtained from a parent or guardian for
each subject.916 The Journal of Thoracic and Cardiovascular SurgData Collection
Detailed information regarding preoperative, perioperative, operative,
and postoperative care was prospectively recorded on standardized case re-
port forms.8 Apart from the shunt type assigned in the trial, subjects re-
ceived standard care at their institutions. The postoperative period was
defined as ending at the Norwood hospitalization discharge, or at the stage
II procedure if the patient was not discharged between the operations. The
goal of our study was to describe the range of care across sites in a large,
well-characterized cohort, rather than to determine the specific underlying
causes of any variation identified, so all data related to perioperative care
were included. Some of the variables examined likely primarily reflect
management practices, whereas others may be related more to patient char-
acteristics or outcome. Several variables may represent a combination of
these factors.
Preoperative variables collected included fetal diagnosis, fetal interven-
tion, endotracheal intubation, use of inhaled gases, and enteral feeding.
Perioperative and operative variables included age at surgery, total support
time and perfusion techniques, type of aortic arch reconstruction (classic
method with an allograft or xenograft patch to create the neoaorta vs direct
anastomosis of the pulmonary artery to the arch), use of standard or mod-
ified ultrafiltration, and the use of various medications in the operating
room (aprotinin, corticosteroids, and a-blockade with phenoxybenzamine
or phentolamine). Perfusion type was defined as either deep hypothermic
cardiac arrest (DHCA), regional cerebral perfusion (RCP), or a combina-
tion of the techniques. Periods as long as 10 minutes of DHCA were in-
cluded in the RCP group to allow for cannula repositioning. Lowest
temperature during bypass was recorded from a core measurement site (na-
sopharynx, rectum, or bladder). The lowest hematocrit was recorded during
bypass before initiation of DHCA or RCP.
Postoperative variables included duration of ventilation and hospital
stay, whether the patient had an open sternum, postoperative interventions,
including interventional cardiac catheterization, cardiac surgery, and extra-
corporeal membrane oxygenation (initiated either in the operating room or
later in the postoperative period), in-hospital death or transplant, type and
route of feeding at discharge, discharge medications, discharge on oxygen,
and enrollment in a home monitoring program (including monitoring of
weight gain, oxygen saturation, or both).
Analysis
Study variables were described with standard summary statistics. Ag-
gregate rates for dichotomous variables and mean SD, median, and inter-
quartile range (IQR) for continuous variables were calculated for the
overall study population. Next, the total number of centers that used a par-
ticular practice or type of care was calculated. For these centers, center-
level descriptive data were calculated. For continuous variables, themedian
value at each site was calculated; for dichotomous variables, the proportion
of cases at each center in which the practice or type of care was used was
calculated.Median, IQR, and rangewere then calculated from these center-
level data. Because of the descriptive nature of the analysis, formal statis-
tical comparisons were not made. All analyses were performed with the
SAS version 9.2 statistical software package (SAS Institute, Inc, Cary, NC).RESULTS
Study Population
Of 555 patients enrolled in the SVR trial, 5 patients had
consent given but did not undergo the Norwood procedure,
and 1 patient was withdrawn immediately after the Norwood
procedure was performed such that no further follow-up in-
formation was collected. In addition, a site that enrolled only
3 patients was excluded. Thus the 546 remaining patients
from 14 trial sites are the basis for analysis. Median birthery c October 2012
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Dweight was 3.1 kg (IQR, 2.8-3.5 kg), median gestational age
was 38 weeks (IQR, 37-39 weeks), and 86% had a diagnosis
of hypoplastic left heart syndrome (vs other single right ven-
tricle defects). Of note, there were no significant differences
in any of these variables across sites.
Preoperative Variables
Preoperative variables are displayed in Table 1. Most pa-
tients (76%) had their condition diagnosed in utero; how-
ever, this varied across centers, ranging from 55% to
85%. Approximately half of patients were intubated preop-
eratively, with a range of 29% to 91% of patients across
centers. Five percent overall were specifically intubated
for transport (range, 1%-15% across 11 sites).
A minority of patients received all other preoperative
therapies and interventions noted in Table 1, including fetal
intervention, use of inhaled gases, and enteral feeding. Al-
though used in a minority of patients overall, these factors
also varied across sites, with the greatest variation seen in
enteral feeding.
Perioperative and Operative Variables
Perioperative and operative variables are displayed in
Table 2. The median age at surgery ranged from 4 to 7
days across sites. Among those who were preterm (<37
weeks’ gestation; n ¼ 64), median age at surgery ranged
from 2 to 23 days across centers. Total support and cross-
clamp times varied more than 2-fold. There was also varia-
tion in the use of DHCA andRCP across sites, alongwith the
lowest core temperature on bypass and lowest hematocrit
(Table 2). Arch reconstruction was accomplished by the
classic method in most cases. Direct anastomosis of the pul-
monary artery to the arch was used in a minority of patients
at 9 sites and in the majority of patients at 1 site. Ultrafiltra-
tion of any typewas used at all sites; at 13 sites, it was used in
most cases. Modified ultrafiltration was used at 10 sites.
Perioperative steroids were used at all sites; they were ad-
ministered to 100% of patients at 7 sites and tomost patients
at all but 1 site. Aprotinin was also used at all sites (while
still available) and was used in most cases at all but 1 site.
There was more variability in the use of a-blockade, withTABLE 1. Variation in preoperative variables
Variable Aggregate rate No. of centers
Fetal diagnosis 76% 14
Fetal intervention* 3% 5
Intubation 48% 14
Inhaled gases
Carbon dioxide 3% 5
Nitrogen 13% 9
Enteral feeding 12% 13
Number of centers refers to the number out of the 14 total centers that used a particular prac
these centers. *Includes both patients who underwent fetal intervention at their center and
The Journal of Thoracic and Ca6 sites not using it at all and the remaining sites using it in
2% to 100% of cases.
Postoperative Variables
Postoperative variables are displayed in in Table 3. There
was a 4-fold difference in duration of ventilation across sites
and a nearly 5-fold variation in intensive care unit (ICU)
stay. Twenty-two patients (4%) overall were kept in the
hospital until their stage II surgery, with a range of 1% to
22% of patients across 8 sites. More than three-quarters
of patients had an open sternum after the Norwood opera-
tion; this also varied across sites, ranging from 35% to
100%. At 7 sites, all patients had an open sternum. Extra-
corporeal membrane oxygenation use ranged from 7% to
35% across sites. Interventional cardiac catheterizations
and cardiac surgery in the postoperative period before dis-
charge were infrequent but variable by site, ranging from
6% to 20% and 3% to 40%, respectively. Five centers
did not perform any interventional catheterizations, and 3
centers did not perform any cardiac surgeries in the postop-
erative period after the Norwood procedure. Overall, 18%
of patients died or underwent transplant during the primary
hospitalization, with a range of 7% to 39% across sites
(Table 3).
All surviving patients were discharged with at least 1
medication. The most frequent discharge medications in-
cluded aspirin (87%), furosemide (85%), ranitidine
(50%), metoclopramide (38%), and digoxin (36%). The
type and route of feeding were highly variable across sites.
Only a third of patients overall were feeding by mouth with-
out any nasogastric or gastric feeds at discharge, and fewer
than half were receiving breast milk (alone or in combina-
tion with formula). A minority of patients (11%) were dis-
charged home with supplemental oxygen, but this varied by
site from 2% to 57%. A third of discharged patients were
enrolled in a home monitoring program; 5 sites did not
have such a program.
DISCUSSION
This analysis describes the wide range of perioperative
care across clinical centers for patients undergoing theCenter-level data
Median Interquartile range Range
73% 71%-82% 55%-85%
3% 2%-4% 1%-17%
50% 38%-64% 29%-91%
16% 1%-20% 1%-40%
15% 9%-36% 1%-55%
11% 4%-22% 1%-100%
tice or type of care. Subsequent center-level descriptive data in the table refer to only
those referred to another institution to undergo fetal intervention.
rdiovascular Surgery c Volume 144, Number 4 917
TABLE 2. Variation in operative and perioperative variables
Variable
Aggregate data Center-level data
Rate Mean ± SD Median (IQR) No. of centers Median IQR Range
Age at Norwood (d) — 5.8  4.1 5 (3-7) 14 5 4-6 4-7
Perfusion data
Total support time (min) — 144  54 139 (105-171) 14 149 124-166 74-189
Crossclamp time (min) — 56  23 53 (40-67) 14 57 48-64 33-73
DHCA only 54% — — 9 97% 22%-100% 3%-100%
DHCA time (min) — 47  18 42 (36-54) 9 51 46-55 33-73
RCP only 24% — — 10 38% 19%-82% 3%-93%
RCP time (min) — 57  17 55 (46-66) 10 52 45%-59 30%-76
RCP flow
(mL/kg/min)
— 42  17 38 (30-50) 10 36 30-49 19-50
Both DHCA and RCP 22% — — 9 42% 18%-60% 4%-87%
DHCA time (min) — 25  16 21 (13-34) 9 24 15-34 12-71
RCP time (min) — 46  22 50 (26-61) 9 48 37-60 23-71
RCP flow
(mL/kg/min)
— 37  16 35 (25-49) 9 30 30-40 19-54
Lowest temperature (C) — 17  2 17 (16-18) 14 17 17-18 15-21
Lowest hematocrit (%) — 30  5 29 (27-32) 14 29 28-31 22-41
Arch reconstruction
Classic 88% — — 14 97% 82%-100% 41%-100%
Direct PA to arch 12% — — 9 15% 4%-22% 3%-59%
Ultrafiltration
Any 84% — — 14 94% 88%-100% 2%-100%
Modified 66% — — 10 94% 88%-100% 48%-100%
Medications
Aprotinin 78% — — 14 87% 60%-93% 43%-100%
Corticosteroids 91% — — 14 99% 96%-100% 33%-100%
a-Blockade 45% — — 8 90% 64%-97% 2%-100%
Number of centers refers to the number out of the 14 total centers that used a particular practice or type of care. Subsequent center-level descriptive data in the table refer to only
these centers. DHCA, Deep hypothermic circulatory arrest; IQR, interquartile range; PA, pulmonary artery; RCP, regional cerebral perfusion; SD, standard deviation.
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DNorwood procedure. Virtually every aspect of preoperative,
operative, and postoperative care evaluated in this analysis
varied across 14 sites participating in the SVR trial. Varia-
tion can foster scientific discovery and innovation and allow
treatment plans to be individually tailored to the patient.
Nevertheless, the degree of variability demonstrated in
our analysis and others may also highlight the limited evi-
dence to guide optimal care in this population and the
lack of best practice guidelines.9 This in turn may play
a role in the wide variability in outcomes after the Norwood
operation. A recent analysis of more than 2000 infants un-
dergoing the Norwood operation across 69 centers showed
that adjusted in-hospital mortality varied by 6-fold from
7% to 42% across centers.10 Data from our study, although
from a smaller subset of hospitals, are similar, with the rate
of in-hospital death or transplant varying from 7% to 39%
across institutions. It has also been shown that variation in
practice can account for a significant proportion of health
care expenditures, which is of particular importance in
this era of rising health care costs.11
This analysis builds on previous surveys of differences in
practice across centers for patients undergoing the Norwood918 The Journal of Thoracic and Cardiovascular Surgoperation. In 2007,Wernovsky and colleagues6 surveyed 52
international centers performing the Norwood operation
and reported wide variation in ICU models of care, opera-
tive and perfusion techniques, medications, feeding regi-
mens, and postoperative monitoring.6 Other surveys
evaluating not only patients undergoing Norwood opera-
tions but others undergoing congenital heart surgery have
found wide variation in perfusion techniques and postoper-
ative care models, including ICU structure and person-
nel.4,12 More recent studies have also analyzed specific
practices in the Norwood population. Johnson and
associates7 evaluated 1283 infants undergoing the Norwood
procedure from 45 centers in the Society of Thoracic Sur-
geons Congenital Heart Surgery Database and showed
that use of delayed sternal closure varied widely across cen-
ters. Other studies have evaluated a wider range of practices
in patients undergoing the Norwood operation but have
been limited by analyzing only survivors to hospital dis-
charge.13,14 This study builds on these previous analyses
through using prospectively collected data related to
perioperative care, as opposed to retrospective survey
methodology, and evaluating a wide range of careery c October 2012
TABLE 3. Variation in postoperative variables
Variable
Aggregate data Center-level data
Rate Mean ± SD Median (IQR) No. of centers Median IQR Range
Total ICU stay (d) — 24  31 14 (9-25) 14 13 12-18 9-44
Total hospital stay (d) — 35  34 24 (17-40) 14 25 22-32 19-44
Ratio of ICU to total stay — 0.7  0.3 0.6 (0.5-1.0) 14 0.6 0.5-0.6 0.5-1.0
Ventilator time (d) — 12  25 7 (5-11) 14 7 6-9 4-16
Extubation within 72 h (%) 18% — — 6 24% 6%-32% 5%-63%
Open sternum (%) 78% — — 14 99% 67%-100% 35%-100%
ECMO (%) 16% — — 13 18% 13%-20% 7%-35%
Interventional catheterization (%) 7% — — 9 8% 6%-11% 6%-20%
Cardiac surgery (%) 8% — — 11 8% 4%-13% 3%-40%
Feeding at discharge
Oral only (%) 33% — — 12 29% 18%-44% 3%-81%
Any oral (%) 78% — — 14 79% 56%-90% 33%-100%
Any G/GJ tube (%) 18% — — 12 20% 13%-27% 2%-72%
Any NG/NJ tube (%) 49% — — 11 60% 53%-78% 8%-100%
Breast milk (any route,%) 48% — — 14 47% 39%-57% 17%-67%
No. of discharge medications — 5  2 5 (4-6) 14 5 4-6 3-6
Discharge with oxygen support 11% — — 11 11% 5%-24% 2%-57%
Home monitoring program 33% — — 9 69% 50%-96% 1%-100%
Death or transplant during Norwood
hospitalization (%)
18% — — 14 17% 15%-30% 7%-39%
Number of centers refers to the number out of the 14 total centers that used a particular practice or type of care. Subsequent center-level descriptive data in the table refer to only
these centers. Data on length of stay and duration of ventilation, along with discharge data, exclude thosewho did not survive to hospital discharge or underwent cardiac transplant
during the same admission (n¼ 97). IQR, Interquartile range; SD, standard deviation; ECMO, extracorporeal membrane oxygenation;G, gastric;GJ, gastrojejunal; ICU, intensive
care unit; NG, nasogastric; NJ, nasojejunal.
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Dencompassing the entire Norwood hospitalization for all
patients enrolled in the SVR trial.
In the field of adult cardiac surgery, it has been shown that
evaluation of variation in care across centers is a critical first
step toward identifying areas of future research, develop-
ment of quality improvement initiatives, and subsequent
implementation of best practice guidelines. Prager and col-
leagues15 recently reported on The Michigan Society of
Thoracic and Cardiovascular Surgeons quality collabora-
tive. This group, composed of all adult cardiac surgery pro-
grams in Michigan, meets regularly to evaluate variation in
practice and program outcomes. Through the adoption of
practices used by high-performing sites, variation in care
is reduced, outcomes are improved, and hospital costs are
lowered. For example, after sharing of protocols to facilitate
timely extubation, variation in duration of ventilation across
sites was reduced, and the overall rate of prolonged ventila-
tion decreased from 19% to 14%.15 The Northern New En-
gland Cardiovascular Disease Study Group pioneered work
in this area in adult cardiac surgery in the 1980s, and their
experience has also shown that a precise assessment of var-
iation in practice and outcomes across institutions is a criti-
cal first step.16 In pediatric cardiology, the Joint Council on
Congenital Heart Disease National Pediatric Cardiology
Quality Improvement Collaborative has recently begun
evaluating practice variation across sites with regard to
feeding and home monitoring practices in the interstageThe Journal of Thoracic and Caperiod between the Norwood and stage II procedures.17
These analyses are ongoing. Efforts are currently underway
to develop a quality improvement collaborative in pediatric
heart surgery.
Few previous studies have evaluated the impact on out-
come of variation in management during the Norwood hos-
pitalization. In their analysis of variation in the use of
delayed sternal closure after the Norwood procedure, John-
son and associates7 found that centers with greater use of de-
layed sternal closure had significantly higher rates of
postoperative infection and prolonged stay, differences
that persisted after accounting for a variety of patient and
center factors. Variation in the use of perioperative cortico-
steroids and its impact on outcome have also been previ-
ously evaluated. In a large study of more than 45,000
patients from 38 centers, perioperative corticosteroid use
was found to vary widely by center, and in subgroup analy-
sis, there was no significant benefit associated with cortico-
steroids in the high-risk group primarily composed of
patients undergoing the Norwood procedure.18 Finally, in-
vestigators have also evaluated variation in center-related
variables and impact on outcome. Analyses of both clinical
and administrative datasets have found variation in ICU
models of care (dedicated cardiac ICU vs general pediatric
ICU) but have shown no significant impact of ICU type on
outcome in patients undergoing theNorwood operation.19,20
Further evaluation of these and other variables examined inrdiovascular Surgery c Volume 144, Number 4 919
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Dthis study will help to determine which aspects of variation
in care are reflective of local practices or underlying patient
characteristics and are not independently associated with
outcome and which are associated with improved
outcomes and should be evaluated as best practices.
Rather than through a single study or trial, this may best
be accomplished through a collaborative effort focused on
sharing of information across sites and continuous quality
improvement to identify best practices, reduce variation in
care, and improve outcomes, similar to initiatives in adult
cardiac surgery.15,16Limitations
There are several limitations to this analysis. This study
focused on a subset of medium- and high-volume centers
performing the Norwood procedure, and only patients en-
rolled in the SVR trial were included. We thus may have ac-
tually underestimated the degree of variation in care across
all patients and across all sites performing this operation. In
this initial analysis, we focused on describing the range of
care across centers in a large cohort and did not evaluate
the potential role of variation in care within centers, random
variation between centers, or change over time. These fac-
tors will require further study. We were inherently limited
to evaluating aspects of perioperative care recorded in the
SVR trial data set. There may be other patient and center-
level variables that are relevant. As noted previously, the
relationship of the variation identified in this study with out-
come will also require further study. Finally, in this analysis
we have not separated out variation in care specifically re-
lated to practice or management from the patient’s severity
of disease, although we did find that the baseline patient
characteristics we examined did not differ across sites. It
is likely that for several of the variables we evaluated,
many factors may play a role and require further analysis.CONCLUSIONS
We have described the wide range of perioperative care
across clinical centers performing the Norwood procedure.
Further analysis is necessary to evaluate the underlying causes
of this variation and relationship of variation in management
to patient outcomes, including survival, neurodevelopmental
outcomes, and cost. These analysesmay aid in planning future
clinical trials, allow us to begin to identify best practices, and
facilitate the development of quality improvement initiatives
to improve quality of care and outcomes across centers for
patients undergoing the Norwood procedure.920 The Journal of Thoracic and Cardiovascular SurgReferences
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